<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Early Alzheimer's Disease Detection from Retinal OCT Images: A UK Biobank Study - Health AI Hub</title>
    <meta name="description" content="This study pioneers the direct classification of raw retinal OCT B-scan images using deep learning for early Alzheimer's disease (AD) detection, a novel approac">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Early Alzheimer's Disease Detection from Retinal OCT Images: A UK Biobank Study</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.05106v1" target="_blank">2511.05106v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-07
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yasemin Turkan, F. Boray Tek, M. Serdar Nazlƒ±, √ñyk√º Eren
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.05106v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.05106v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This study pioneers the direct classification of raw retinal OCT B-scan images using deep learning for early Alzheimer's disease (AD) detection, a novel approach for AD prediction. Utilizing data from the UK Biobank, fine-tuned pretrained models like ResNet-34 achieved an AUC of 0.62 for detection within four years of imaging. Explainability analyses confirmed localized structural differences in the central macular subfield, establishing a baseline for this challenging task.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research explores a non-invasive and potentially accessible method for early Alzheimer's disease detection through retinal OCT imaging, which could enable earlier therapeutic interventions and disease management strategies before significant neurodegeneration occurs.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Applying deep learning models (e.g., ResNet, RETFound transformer) to analyze raw Optical Coherence Tomography (OCT) retinal images to predict the early onset of Alzheimer's disease, potentially several years before clinical diagnosis.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>First application of deep learning directly to raw retinal OCT B-scans for early Alzheimer's disease (AD) prediction in the literature.</li>
                    
                    <li>Aims for early detection, which is more challenging than diagnosis as imaging precedes clinical diagnosis by several years.</li>
                    
                    <li>Pretrained deep learning models (ImageNet-based, OCT-specific RETFound transformer) were fine-tuned using subject-level cross-validation datasets from the UK Biobank, matched for age, sex, and imaging instances.</li>
                    
                    <li>Overfitting was addressed using standard and OCT-specific augmentation techniques, alongside a year-weighted loss function prioritizing cases diagnosed within four years of imaging.</li>
                    
                    <li>ResNet-34 produced the most stable results, achieving an Area Under the Curve (AUC) of 0.62 in the 4-year cohort for AD prediction.</li>
                    
                    <li>Explainability analyses confirmed localized structural differences in the central macular subfield between AD and control groups.</li>
                    
                    <li>The study provides a baseline for OCT-based AD prediction, highlighting challenges and the need for larger datasets and multimodal approaches.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved fine-tuning and evaluating multiple pretrained deep learning models (e.g., ResNet-34, RETFound transformer) on raw OCT B-scan images sourced from the UK Biobank. Subject-level cross-validation datasets were used, matched for age, sex, and imaging instances. Overfitting in the small, high-dimensional dataset was mitigated through standard and OCT-specific data augmentation techniques and a year-weighted loss function prioritizing cases with AD diagnosis within four years. Explainability analyses were performed to localize detected structural differences.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>ResNet-34 demonstrated the most stable performance, achieving an AUC of 0.62 for predicting AD diagnosis within four years of imaging. Explainability analyses successfully identified localized structural differences in the central macular subfield between the AD and control groups, confirming the retinal changes detected by the model. The study underscores the significant challenge of detecting subtle retinal biomarkers for AD years before clinical diagnosis.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>While the current AUC of 0.62 is below the threshold for immediate clinical application, this study provides a vital proof-of-concept and baseline for non-invasive, OCT-based early AD detection. It suggests the potential for developing future screening tools that could identify individuals at risk for AD much earlier, facilitating early intervention strategies, although substantial further research is required.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The primary limitation is that the achieved predictive performance (AUC of 0.62) is currently insufficient for clinical application. The study also points to the inherent challenges of working with a 'small, high-dimensional dataset' and the difficulty in detecting subtle retinal biomarkers several years prior to AD diagnosis.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors recommend pursuing larger datasets to improve model training and generalization. Additionally, they suggest exploring multimodal approaches, combining OCT imaging with other diagnostic data or biomarkers, to enhance the accuracy and robustness of early AD prediction.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Ophthalmology</span>
                    
                    <span class="tag">Geriatrics</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                    <span class="tag">Artificial Intelligence in Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Alzheimer's disease</span>
                    
                    <span class="tag tag-keyword">Optical Coherence Tomography</span>
                    
                    <span class="tag tag-keyword">Deep learning</span>
                    
                    <span class="tag tag-keyword">Early detection</span>
                    
                    <span class="tag tag-keyword">Retina</span>
                    
                    <span class="tag tag-keyword">UK Biobank</span>
                    
                    <span class="tag tag-keyword">Neurodegeneration</span>
                    
                    <span class="tag tag-keyword">Biomarker</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Alterations in retinal layer thickness, measurable using Optical Coherence
Tomography (OCT), have been associated with neurodegenerative diseases such as
Alzheimer's disease (AD). While previous studies have mainly focused on
segmented layer thickness measurements, this study explored the direct
classification of OCT B-scan images for the early detection of AD. To our
knowledge, this is the first application of deep learning to raw OCT B-scans
for AD prediction in the literature. Unlike conventional medical image
classification tasks, early detection is more challenging than diagnosis
because imaging precedes clinical diagnosis by several years. We fine-tuned and
evaluated multiple pretrained models, including ImageNet-based networks and the
OCT-specific RETFound transformer, using subject-level cross-validation
datasets matched for age, sex, and imaging instances from the UK Biobank
cohort. To reduce overfitting in this small, high-dimensional dataset, both
standard and OCT-specific augmentation techniques were applied, along with a
year-weighted loss function that prioritized cases diagnosed within four years
of imaging. ResNet-34 produced the most stable results, achieving an AUC of
0.62 in the 4-year cohort. Although below the threshold for clinical
application, our explainability analyses confirmed localized structural
differences in the central macular subfield between the AD and control groups.
These findings provide a baseline for OCT-based AD prediction, highlight the
challenges of detecting subtle retinal biomarkers years before AD diagnosis,
and point to the need for larger datasets and multimodal approaches.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>